Neoadjuvant pembrolizumab-carboplatin-paclitaxel in locally advanced squamous cell carcinoma of the oral cavity: A case report and literature review

Head and neck cancers are being diagnosed more frequently in elderly patients and at advanced stages. In these cases, standard treatment methods are often not feasible due to patient frailty and malnutrition. A few trials have demonstrated the safety and effectiveness of immune checkpoint inhibitors...

Full description

Bibliographic Details

Published in:	Oral Oncology Reports
Main Authors:	Abdulrahman Hesham, Fawaz AlOtaibi, D. David Kim, Yousef Alshamrani, Joao Hyppolito, Katie Jubala
Format:	Article
Language:	English
Published:	Elsevier 2024-09-01
Subjects:	Neoadjuvant immunotherapy Pembrolizumab Paclitaxel Carboplatin Oral cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906024004424